Industries > Healthcare > Healthcare Competitive Intelligence (CI) Services

Healthcare Competitive Intelligence (CI) Services

We help you evaluate new entrant threats, track the current players and technology, check the pulse and power of the suppliers and buyers, and the availability of substitutes and counterfeits.

Blogs | Emerging Healthcare Technology Outlook 2023

Why Healthcare Competitive Intelligence?

How do you differentiate ’information’ from ‘intelligence’? SG Analytics (SGA) uses CI tools to convert information with intelligence into actionable insights that support growth and new revenue.

At SGA, we believe that credible and legit information is the starting point. Digitization of payer and provider data has filled the public domain with numbers, statistics, and bits of data about patients, companies, drugs, medical equipment, and their preferences.  The overload of information has created complexity in understanding the true essence of data; information is only considered ’intelligent’ when it is cleaned, filtered, and analyzed. 

SGA helps clients create a link between information and business strategies and decisions. We offer alerts, region, and product-specific dashboards on competitive intelligence, smart reports on competitors, and customized solutions. CI is critical only until it is in the published or public domain. Our CI models have saved millions of dollars for our clients, and our samples can tell you more about the same. 

Healthcare Competitive Intelligence

What We Offer

SGA understands your end goal and the objective for the exercise before creating a work plan for healthcare competitive intelligence projects. Our experts speak your language and understand the threats, opportunities, challenges, and strengths of different therapeutic segments.

Our experts understand and map peers on a company level as well as product level. We track 5,000 pharmaceutical companies and 800 key medical device companies daily and understand their launch strategies, pipeline, and roadmap. Our AI/ML tools (proprietary) are time-tested to gather information quickly from the desired market.

Our experts understand and map peers on a company level as well as product level. We track 5,000 pharmaceutical companies and 800 key medical device companies daily and understand their launch strategies, pipeline, and roadmap. Our AI/ML tools (proprietary) are time-tested to gather information quickly from the desired market

Our team of data analysts is proficient in data crawling, data gathering, data cleansing, and data sorting before interpreting the insights from the most relevant information.

Why SGA

Industry Leaders

SGA thrives by its brand promise - Life is Possible, and is recognized as the trusted healthcare market research consulting company in the USA.

12+ Languages

Language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English experts (US/UK).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with analytical and ML/AI capabilities, helps in presenting credible competitive information.

Who We Work With

Insights

SGA Whitepaper Market Entry in 2023

Whitepapers

Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

SGA Whitepaper Blue Ocean Strategy

Whitepapers

The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....

SGA Healthcare Whitepaper Healthcare Consulting & Analytics

Whitepapers

What Happens When You Invest in Healthcare Consulting and Analytics?

Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...

We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high quality, white labelled research coverage.